These 3 Catalysts Could Push UnitedHealth Stock (UNH) Higher
Don't Miss TipRanks' Half-Year Sale
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The first big catalyst is the improved Medicare Advantage (MA) payment outlook. Earlier this year, U.S. regulators announced a 5.06% rate increase for MA plans in 2026, which was much higher than the 2.23% previously expected. This is important because UnitedHealth relies heavily on MA plans for revenue, through both its insurance business and its Optum services. As a result, higher rates should ease pressure on earnings, especially after a tough 2025 that has been marked by increased medical costs and regulatory investigations. Simply put, more funding means more breathing room for UnitedHealth's bottom line.
The second catalyst is a leadership shakeup at Optum Health. After struggling with lower patient volumes and billing issues, UnitedHealth named Patrick Conway, an experienced healthcare executive, as CEO of Optum Health. The hope is that new leadership will help stabilize the business and boost performance. Finally, the third positive factor is reduced regulatory risk. A proposed 25% funding cut to Medicaid and ACA programs was blocked in the U.S. Senate, which helps remove uncertainty for companies like UnitedHealth. When you put it all together—better funding, stronger leadership, and fewer policy threats—UnitedHealth looks better positioned for a recovery.
What Is the Future of UNH Stock?
Turning to Wall Street, analysts seem to agree that the stock can recover since they have a Moderate Buy consensus rating on UNH stock based on 18 Buys, seven Holds, and one Sell assigned in the past three months. Furthermore, the average UNH price target of $361.91 per share implies 17.2% upside potential.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
What You Need To Know Ahead of GE Vernova's Earnings Release
Cambridge, Massachusetts-based GE Vernova Inc. (GEV) engages in the provision of various products and services that generate, transfer, orchestrate, convert, and store electricity. It operates through Power, Wind, and Electrification segments. With a market cap of $137.9 billion, GE Vernova's operations span the Americas, Indo-Pacific, and EMEA. The industrial giant is set to unveil its second-quarter results before the market opens on Wednesday, Jul. 23. Ahead of the event, analysts expect GEV to report earnings of $1.65 per share, up 132.4% from the profit of $0.71 per share reported in the year-ago quarter. The company has surpassed the Street's bottom-line projections in three of the past four quarters, while missing on one other occasion. UnitedHealth Stock Is One of the Worst-Performing S&P 500 Stocks in 2025. Should You Buy the Dip? AI Isn't Just About Nvidia: 2 Rising Stars in the Artificial Intelligence Race 'It's a Miracle': Nvidia CEO Says Their New Technology Takes 'AI Supercomputing to a Whole New Level' Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. For the full fiscal 2025, its earnings are expected to come in at $7.21 per share, up 200.4% from $2.40 per share reported in the year-ago quarter. While in fiscal 2026, its earnings are expected to rise 62.7% year-over-year to $11.73 per share. GEV stock has surged by an impressive 199.4% over the past 52 weeks, outperforming the Industrial Select Sector SPDR Fund's (XLI) 22.8% surge and the S&P 500 Index's ($SPX) 13.4% uptick during the same time frame. GEV stock rose 3.1% following the release of its better-than-expected Q1 earnings on Apr. 23. The company's total revenues increased 10.6% year-over-year to approximately $8 billion, exceeding the Street's expectations. Moreover, its adjusted EBITDA margin expanded by 310 basis points from the prior year's quarter to 5.7% and its adjusted EBITDA surged by a whopping 141.8% year-over-year to $457 million. The company's net income amounted to $264 million, compared to a net loss of $106 million in the previous year's quarter. Similarly, GEV's EPS also came in at $0.91, compared to a loss per share of $0.47 in the year-ago quarter, and surpassed the consensus estimates by an impressive 102.2%. The stock holds a consensus 'Strong Buy' rating overall. Of the 26 analysts covering the stock, opinions include 19 'Strong Buys,' two 'Moderate Buys,' and five 'Holds.' As of writing, the stock is trading notably above its mean price target of $479.12. On the date of publication, Aditya Sarawgi did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
38 minutes ago
- Yahoo
Earnings Preview: What to Expect From Old Dominion's Report
With a market cap of $35.9 billion, Old Dominion Freight Line, Inc. (ODFL) is a leading U.S.-based less-than-truckload (LTL) freight carrier known for its premium service, operational efficiency, and strong on-time delivery performance. The North Carolina-based company operates a nationwide network of service centers, offering regional, inter-regional, and national LTL services. ODFL set to release its second-quarter results before the markets open on Wednesday, Jul. 30. Ahead of the event, analysts expect ODFL to report a non-GAAP profit of $1.30 per share, down 12.2% from $1.48 per share reported in the year-ago quarter. On the bright side, the company has matched or surpassed the Street's earnings estimates in each of the past four quarters. UnitedHealth Stock Is One of the Worst-Performing S&P 500 Stocks in 2025. Should You Buy the Dip? AI Isn't Just About Nvidia: 2 Rising Stars in the Artificial Intelligence Race 'It's a Miracle': Nvidia CEO Says Their New Technology Takes 'AI Supercomputing to a Whole New Level' Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. For FY2025, ODFL is expected to deliver a non-GAAP EPS of $5.16, down 5.8% from $5.48 in fiscal 2024. However, in fiscal 2026, ODFL's earnings are expected to surge 17.6% year-over-year to $6.07 per share. ODFL stock has declined 6% over the past 52 weeks, significantly underperforming the S&P 500 Index's ($SPX) 13.4% rise and the Industrial Select Sector SPDR Fund's (XLI) 22.8% gains during the same time frame. On April 23, Old Dominion Freight Line surged marginally following the release of its better-than-expected Q1 results. Despite ongoing volume declines due to a sluggish macroeconomic backdrop, the company posted revenue of $1.4 billion, down 5.8% year-over-year but ahead of Wall Street expectations. Profitability came under pressure, with net income slipping 12.9% to $254.7 million, reflecting margin headwinds. The consensus opinion on ODFL stock is fairly upbeat, with an overall 'Moderate Buy' rating. Out of the 21 analysts covering the stock, six recommend 'Strong Buy,' one advises 'Moderate Buy,' 12 suggest 'Hold,' and two advocate a 'Strong Sell' rating. The stock currently trades above its mean price target of $166.19. On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio
Yahoo
39 minutes ago
- Yahoo
UBS Lowers UNH Target Amid Conservative 2025 Outlook from CEO
UnitedHealth Group Incorporated (NYSE:UNH) ranks among the best set-it-and-forget-it stocks to buy. While maintaining its Buy rating, UBS reduced its price target for UnitedHealth Group Incorporated (NYSE:UNH) from $400 to $385 on June 25. The adjustment followed remarks made by UnitedHealth's returning CEO at the company's June 2 annual meeting, when he stated that management would restore its 2025 projection during the second-quarter earnings release on July 29. Ken Wolter/ UBS pointed out that the investment community has taken CEO Hemsley's description of the forecast as 'prudent' as a hint that guidance would be more conservative than the consensus of $22.50 earnings per share set on June 2. UBS recently revised its own predictions to reflect the recent movement in investor expectations toward a $20 EPS estimate for 2025. UnitedHealth Group Incorporated (NYSE:UNH) is a renowned US multinational corporation that provides managed healthcare and insurance services. The company operates through four main segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Sign in to access your portfolio
